Friday the 13th. Yeah, I know, lots of people are superstitious.
But, not Dr. Bryan Schneider (of Indiana University, with Drs. M Raodvich, M Jiang, C Chitambar, R Nanda, C Falkson, FC Lynce, C Gallagher, C Isaacs, M. Blaya, E Paplomata, R Walling, K Daily, R Mahtani, M Thompson, R Graham, M Cooper, D Pavlick, L Albacker, J Gregg, C Bales, BA Hancock, E Cantor, F Shen, A Stomiolo, S Badve, T Ballinger, and K Miller). Nope. They presented their clinical trial results at the 2019 San Antonio Breast Cancer Symposium that day. Their paper, GS5-02, Detection of circulating tumor DNA (ctDNA) after neoadjuvant chemotherapy is significantly associated with disease recurrence in early-stage triple-negative breast cancer (TNBC): Preplanned correlative results from clinical trial BRE12-158 ? (I know, I know… That’s a mouthful. But here’s what it really is- a new detection technique for solid tumors- like those that obtain for breast cancer.)
Continue reading Early Detection of Breast Cancer Recurrence
